为什么美国医疗服务交易复杂？
美国医疗服务企业可能拥有高质量患者基础、专业医生、成熟运营流程和稳定现金流。但医疗行业高度监管，买方不能只按EBITDA倍数判断交易。
不同州对医生执业、企业持有医疗机构、转诊安排和管理服务结构有不同限制。
估值重点
买方应关注收入来源、付款方组合、医生生产力、患者留存、同店增长、租约、设备状态、人员成本、保险理赔和正常化EBITDA。
如果收入依赖少数医生、单一付款方或不可持续营销渠道，估值应反映集中风险。
尽职调查重点
尽调应覆盖牌照、付款方合同、HIPAA、反回扣规则、医疗事故索赔、医生雇佣协议、转诊来源、账单编码、保险拒付和应收账款质量。
跨境买方还应提前评估监管审批、声誉沟通和关键医生留任安排。
Lyndon如何协助
Lyndon可协助中国买方、美国医疗服务企业主和顾问准备交易定位、估值、资料室、风险清单和谈判执行。
About the Author
Daniel Bae
Co-founder & CEO, Lyndon Advisory
Daniel is an investment banker with 15+ years of experience in M&A, having advised on deals worth over US$30 billion. His career spans Citi, Moelis, Nomura, and ANZ across London, Hong Kong, and Sydney. He holds a combined Commerce/Law degree from the University of New South Wales. Daniel founded Lyndon Advisory to solve the pain points in M&A, enabling bankers to focus on what matters most — delivering trusted advice to clients.
About Lyndon Advisory
Lyndon Advisory is an M&A advisory firm built for Asia Pacific. We help business owners sell their companies and investors make strategic acquisitions with senior-led execution, disciplined process management, and AI-supported buyer intelligence.
Learn about selling your business